Sarepta Therapeutics, Inc.
SRPT· Nasdaq
SRPTSarepta Therapeutics, Inc.
Filed Nov 8, 2011 · 10-Q · 39 days after period end · 0001193125-11-302239
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Net Income | -$4.02M | -$7.29M |
| EPS Diluted | -$0.18 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 8, 2011 · 39 d after period end
